CG
STRO icon

Cutler Group’s Sutro Biopharma STRO Stock Holding History

Cutler Group’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-56
Closed -$4K – 5650
2022
Q1 		$4K Sell
56
-200
-78% -$19K ﹤0.01% 4331
2021
Q4 		$38K Hold
256
– – ﹤0.01% 2617
2021
Q3 		$48K Hold
256
– – ﹤0.01% 2542
2021
Q2 		$47K Sell
256
-100
-28% -$19.6K ﹤0.01% 2532
2021
Q1 		$81K Buy
+356
New +$84.5K ﹤0.01% 1949

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Cutler Group's STRO Position: Q2 2022 in Review

Cutler Group sold out of Sutro Biopharma (STRO) in Q2 2022, closing a stake of 56 shares — an estimated $4K sold.

Cutler Group first reported a position in STRO in Q1 2021 and held it in 5 quarters. The position peaked at $81K in Q1 2021. 114 funds tracked by Wall St. Rank hold STRO as of Q2 2022.

  • Cutler Group reported no remaining Sutro Biopharma position as of Q2 2022 after selling out during the quarter.
  • Cutler Group sold 56 Sutro Biopharma shares in Q2 2022, an estimated $4K.
  • Cutler Group first reported a position in Sutro Biopharma in Q1 2021 and held it in 5 quarters.
  • Cutler Group's Sutro Biopharma position peaked at $81K in Q1 2021.
  • 114 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2022.

Based on Cutler Group's 13F filing for Q2 2022, filed 4 Aug 2022.